KDM1A Facilitates Oncogenic Potential in Colorectal Cancer Progression Through the Activation of AXIN/GSK3β/β‐Catenin Signaling Pathways: Evidence From Integrated Transcriptomics and In Vitro Studies
The Journal of Gene Medicine · 2025
DOI: 10.1002/jgm.70053 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2025. Verfasst von Sathan Raj Natarajan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medi…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Histone Demethylases, beta Catenin, Glycogen Synthase Kinase 3 beta. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) is a major cause of cancer‐related death and is driven by epigenetic alterations. KDM1A, a key histone demethylase, has a poorly defined role in CRC. This study investigates its molecular mechanisms using bioinformatic and experimental analyses to better understand its impact on tumor progression.
Methods
KDM1A expression was analyzed using TCGA datasets to assess its correlation with CRC progression and patient survival. CRC cell lines were treated with the KDM1A‐specific inhibitor GSK2879552, both alone and in combination with 5‐Aza and XAV939. Functional assays, including cell proliferation, cell cycle analysis, ROS measurement, glycolysis assessment, and G6PD activity, were performed to evaluate the effects of KDM1A inhibition. Protein and gene expression were examined by Western blotting and RT‐PCR analysis.
Results
KDM1A expression was significantly upregulated in advanced CRC and was associated with poor survival. Treatment with GSK2879552 inhibited CRC cell proliferation, induced G1‐phase arrest, reduced aerobic glycolysis, and increased ROS levels. Combination with 5‐Aza and XAV939 further enhanced the antitumor effects, demonstrating synergistic potential in CRC cells.
Conclusions
KDM1A regulates CRC progression by modulating epithelial‐mesenchymal transition (EMT), metabolism, and Wnt signaling. Targeting KDM1A with GSK2879552 represents a promising therapeutic strategy for CRC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
- Department of Food Science and Nutrition, College of Food and Agriculture Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia.
- Department of Biochemistry, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
- Central Research Laboratory, Meenakshi Ammal Dental College and Hospital, Meenakshi, Academy of Higher Education and Research (Deemed to be University), Chennai, India.
- Phytochemistry and Pharmacotherapy Laboratory, Department of Dermatology, Saveetha Medical College & Hospital (SMCH), Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, India.
Zitieren
APA
Natarajan, S. R., Krishnamoorthy, R., Alshuniaber, M. A., Gatasheh, M. K., Rajagopal, P., Veeraraghavan, V. P., Palanisamy, C. P., & Jayaraman, S. (2025). KDM1A Facilitates Oncogenic Potential in Colorectal Cancer Progression Through the Activation of AXIN/GSK3β/β‐Catenin Signaling Pathways: Evidence From Integrated Transcriptomics and In Vitro Studies. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.70053
Vancouver
Natarajan SR, Krishnamoorthy R, Alshuniaber MA, Gatasheh MK, Rajagopal P, Veeraraghavan VP, et al. KDM1A Facilitates Oncogenic Potential in Colorectal Cancer Progression Through the Activation of AXIN/GSK3β/β‐Catenin Signaling Pathways: Evidence From Integrated Transcriptomics and In Vitro Studies. The Journal of Gene Medicine. 2025. doi:10.1002/jgm.70053
BibTeX
@article{Natarajan2025,
author = {Natarajan, Sathan Raj and Krishnamoorthy, Rajapandiyan and Alshuniaber, Mohammad A and Gatasheh, Mansour K and Rajagopal, Ponnulakshmi and Veeraraghavan, Vishnu Priya and Palanisamy, Chella Perumal and Jayaraman, Selvaraj},
title = {KDM1A Facilitates Oncogenic Potential in Colorectal Cancer Progression Through the Activation of AXIN/GSK3β/β‐Catenin Signaling Pathways: Evidence From Integrated Transcriptomics and In Vitro Studies},
journal = {The Journal of Gene Medicine},
year = {2025},
doi = {10.1002/jgm.70053}
}
EUVIMED